stockportfolio.pro
Bristol-Myers Squibb Company Net Income 2007–2025
Bristol-Myers Squibb Company (BMY) annual net income by fiscal year, computed from SEC filings. Compound growth +6.8%/yr over 18 years.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $7.05B | 14.6% | +178.8% |
| FY 2024 | $-8.95B | -18.5% | -211.5% |
| FY 2023 | $8.03B | 17.8% | +26.8% |
| FY 2022 | $6.33B | 13.7% | -9.5% |
| FY 2021 | $6.99B | 15.1% | +177.6% |
| FY 2020 | $-9.02B | -21.2% | -362.1% |
| FY 2019 | $3.44B | 13.2% | -30.1% |
| FY 2018 | $4.92B | 21.8% | +388.6% |
| FY 2017 | $1.01B | 4.8% | -77.4% |
| FY 2016 | $4.46B | 22.9% | +184.8% |
| FY 2015 | $1.56B | 9.5% | -21.9% |
| FY 2014 | $2.00B | 12.6% | -21.8% |
| FY 2013 | $2.56B | 15.6% | +30.8% |
| FY 2012 | $1.96B | 11.1% | -47.2% |
| FY 2011 | $3.71B | 17.5% | +19.6% |
| FY 2010 | $3.10B | 15.9% | -70.8% |
| FY 2009 | $10.61B | 56.4% | +102.2% |
| FY 2008 | $5.25B | 29.6% | +142.4% |
| FY 2007 | $2.17B | 13.9% | — |
Source: Bristol-Myers Squibb Company SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Bristol-Myers Squibb Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBristol-Myers Squibb Company — frequently asked questions
What is Bristol-Myers Squibb Company's net income?
Bristol-Myers Squibb Company (BMY) reported net income of $7.05B for fiscal year 2025, per its SEC filings.
How has Bristol-Myers Squibb Company's net income changed over time?
Between fiscal 2007 and 2025, BMY's net income grew at roughly 6.8% per year (compound annual rate), from $2.17B to $7.05B.
Where does this data come from?
Figures are computed from Bristol-Myers Squibb Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.